Venture Fund Vi Lparch Vent... Net Worth

The estimated Net Worth of Venture Fund Vi Lparch Vent... is at least $18.6 Milión dollars as of 11 December 2017. Venture Vent owns over 266,000 units of Quanterix Corp stock worth over $18,559,846 and over the last 7 years Venture sold QTRX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Venture Vent QTRX stock SEC Form 4 insiders trading

Venture has made over 1 trades of the Quanterix Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently Venture bought 266,000 units of QTRX stock worth $3,990,000 on 11 December 2017.

The largest trade Venture's ever made was buying 266,000 units of Quanterix Corp stock on 11 December 2017 worth over $3,990,000. On average, Venture trades about 133,000 units every 0 days since 2017. As of 11 December 2017 Venture still owns at least 1,537,684 units of Quanterix Corp stock.

You can see the complete history of Venture Vent stock trades at the bottom of the page.

Insiders trading at Quanterix Corp

Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister a Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.

What does Quanterix Corp do?

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).

Complete history of Venture Vent stock trades at Quanterix Corp

Quanterix Corp executives and stock owners

Quanterix Corp executives and other stock owners filed with the SEC include:

• E. Kevin Hrusovsky,
  Chairman of the Board, President, Chief Executive Officer
• John Fry,
  General Counsel, Secretary
• Amol Chaubal,
  Chief Financial Officer
• E. Kevin Hrusovsky,
  Chairman & CEO
• Dawn Mattoon,
  Senior Vice President - Research Products
• David Duffy,
  Senior Vice President, Research & Development and Chief Technology Officer
• Sarah Hlavinka,
  Independent Director
• Mark Roskey,
  Senior Vice President - Commercial and Accelerator
• Martin Madaus,
  Lead Independent Director
• Paul Meister,
  Independent Director
• Keith Crandell,
  Independent Director
• Marijn Dekkers,
  Independent Director
• David Walt,
  Independent Director
• Dr. David R. Walt Ph.D.,
  Co-Founder, Chairman of Scientific Advisory Board & Independent Director
• William Geist,
  Chief Operating Officer
• Dr. Masoud Toloue Ph.D.,
  Pres, CEO & Director
• Dr. Dawn R. Mattoon Ph.D.,
  Sr. VP of Diagnostics
• Dr. Mark T. Roskey Ph.D.,
  Sr. VP of Strategic Partnerships
• Dr. David C. Duffy Ph.D.,
  Sr. VP of R&D and CTO
• Michael A. Doyle,
  CFO & Treasurer
• Masoud Toloue,
  Pres & Head of Diagnostics Bus.
• David Panzerella,
  VP of Sales
• William Geist,
  Chief Operating Officer
• Bruce J. Bal,
  VP of Operations, Service & Quality
• John J. Fry,
  Gen. Counsel & Corp. Sec.
• Brian J Blaser,
  
• Shawn Stetson,
  Interim CFO and Treasurer
• Venture Fund Vi Lparch Vent...,
  
• Ventures Fund 2004 L P Flag...,
  
• Capital Venture Investors, ...,
  
• Ernest Orticerio,
  SVP Finance and Corporate Dev
• Douglas G. Cole,
  
• John M Connolly,
  
• Jackson Streeter,
  SVP, Corp Dev & Strategy
• Bruce J Bal,
  VP of Ops, Service and Quality
• Joseph Driscoll,
  Chief Financial Officer
• Amee Desjourdy,
  Chief Human Resource Officer
• Laurie J Olson,
  
• Michael A Doyle,
  CFO and Treasurer
• Masoud Toloue,
  President & CEO
• Karen Flynn,
  
• William P Donnelly,
  
• Vandana Sriram,
  Chief Financial Officer
• Jeffrey Thomas Elliott,